Quarterly report · Q3
4021.TEDINET S100Q6HC
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥159.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥141.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥38.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥33.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥35.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥36.0bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥30.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥31.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥25.9bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥276.6bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥254.7bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.4bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥71.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥216.2bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥199.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥25.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.2bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥37.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥13.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.8bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥35.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥217.99 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.21 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.58 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.51 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥343m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥80.6bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | −¥22.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥58.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥4.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥48.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥29.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥62.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥50.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥20.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥10m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥74.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥57.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥17.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥239.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥181.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥58.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥42.9bn |
| Otherother segments | revenue | 2021-04-01 → 2021-12-31 | ¥16.5bn |
| Otherother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥7.1bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9.4bn |
| Otherother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥193m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥64.0bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-12-31 | −¥16.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥47.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥3.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥36.9bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥32.0bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥4.9bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥9.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥27.6bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥8.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥60.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥51.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥20.7bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.3bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥35m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥58.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥42.8bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥15.8bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥205.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥157.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥47.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥37.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 529
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYTDDuration | 159234000000 | JPY |
| Cost of sales | Prior1YTDDuration | 70895000000 | JPY |
| Cost of sales | CurrentYTDDuration | 80785000000 | JPY |
| Gross profit | Prior1YTDDuration | 70441000000 | JPY |
| Gross profit | CurrentYTDDuration | 78449000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 36506000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 39638000000 | JPY |
| Operating income | Prior1YTDDuration | 33935000000 | JPY |
| Operating income | CurrentYTDDuration | 38811000000 | JPY |
| Interest income noi | Prior1YTDDuration | 31000000 | JPY |
| Interest income noi | CurrentYTDDuration | 154000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 521000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 606000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 840000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 1398000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 309000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 912000000 | JPY |
| Other noi | Prior1YTDDuration | 712000000 | JPY |
| Other noi | CurrentYTDDuration | 485000000 | JPY |
| Non operating income | Prior1YTDDuration | 2415000000 | JPY |
| Non operating income | CurrentYTDDuration | 3557000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 55000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 165000000 | JPY |
| Loss on disposal of noncurrent assets noe | Prior1YTDDuration | 386000000 | JPY |
| Loss on disposal of noncurrent assets noe | CurrentYTDDuration | 584000000 | JPY |
| Pland stop loss noe | Prior1YTDDuration | 40000000 | JPY |
| Pland stop loss noe | CurrentYTDDuration | 86000000 | JPY |
| Other noe | Prior1YTDDuration | 89000000 | JPY |
| Other noe | CurrentYTDDuration | 190000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 571000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 1026000000 | JPY |
| Ordinary income | Prior1YTDDuration | 35779000000 | JPY |
| Ordinary income | CurrentYTDDuration | 41341000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 3316000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 3316000000 | JPY |
| Extraordinary income | CurrentYTDDuration | － | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 298000000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | － | JPY |
| Business structure improvement expenses el | Prior1YTDDuration | 2165000000 | JPY |
| Business structure improvement expenses el | CurrentYTDDuration | － | JPY |
| Loss on business of subsidiaries and affiliates el | Prior1YTDDuration | 626000000 | JPY |
| Loss on business of subsidiaries and affiliates el | CurrentYTDDuration | － | JPY |
| Extraordinary loss | Prior1YTDDuration | 3090000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | 36005000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 41341000000 | JPY |
| Income taxes current | Prior1YTDDuration | 9205000000 | JPY |
| Income taxes current | CurrentYTDDuration | 9557000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 881000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |